Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study

Abstract

The apparent association between SSRI use and congenital malformations of the heart may be confounded by indications. The moderate absolute risk increase combined with uncertainty for causality still requires the risk versus benefit to be evaluated in each individual case.